Table 1. Baseline Demographic and Clinical Characteristics of the Enrolled Patients in the Randomized Clinical Trial.
| Characteristics | Patients, No. (%) | |
|---|---|---|
| Vein-First Group (n = 43) | Artery-First Group (n = 43) | |
| Age, y | ||
| <60 | 11 (25.6) | 11 (25.6) |
| ≥60 | 32 (74.4) | 32 (74.4) |
| Sex | ||
| Male | 25 (58.1) | 26 (60.5) |
| Female | 18 (41.9) | 17 (39.5) |
| Comorbidity | ||
| No | 17 (39.5) | 21 (48.8) |
| Yes | 26 (60.5) | 22 (51.2) |
| Current or former smoking | ||
| No | 23 (53.5) | 24 (55.8) |
| Yes | 20 (46.5) | 19 (44.2) |
| Family cancer history | ||
| No | 37 (86.0) | 39 (90.7) |
| Yes | 6 (14.0) | 4 (9.3) |
| Tumor location | ||
| Right lobe | 27 (62.8) | 28 (65.1) |
| Left lobe | 16 (37.2) | 15 (34.9) |
| Tumor size, cm | ||
| <3 | 23 (53.5) | 23 (53.5) |
| ≥3 | 20 (46.5) | 20 (46.5) |
| Histological type | ||
| Adenocarcinoma | 31 (72.1) | 29 (67.4) |
| Nonadenocarcinoma | 12 (27.9) | 14 (32.6) |
| Pathological TNM stage | ||
| I | 22 (51.2) | 21 (48.8) |
| II | 10 (23.3) | 10 (23.3) |
| III | 9 (20.9) | 12 (27.9) |
| IV | 2 (4.6) | 0 (0.0) |